Parkman Healthcare Partners LLC
An institutional investment manager in STAMFORD, CT. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1777015.
- Reported value$976.8m
- Positions77
Holdings: 77 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| MBX Biosciences IncMBX | COM | 55287L101 | 44.2 | 4.5% | 800,173 | Added+136 | |
| ELI Lilly & CoLLY | COM | 532457108 | 42.0 | 4.3% | 35,000 | Added+384 | |
| CVS Health CorpCVS | COM | 126650100 | 40.5 | 4.1% | 391,791 | Added+4,485 | |
| Dexcom IncDXCM | COM | 252131107 | 36.0 | 3.7% | 534,767 | Reduced−155,055 | |
| PTC Therapeutics IncPTCT | COM | 69366J200 | 35.5 | 3.6% | 435,691 | Added+4,327 | |
| Arcus Biosciences IncRCUS | COM | 03969F109 | 28.3 | 2.9% | 919,266 | Reduced−288,008 | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 26.1 | 2.7% | 485,661 | Added+253,568 | |
| Viridian Therapeutics IncVRDN | COM | 92790C104 | 25.3 | 2.6% | 1,377,576 | Added+819,640 | |
| Agios Pharmaceuticals IncAGIO | COM | 00847X104 | 24.8 | 2.5% | 669,046 | Added+265,521 | |
| Inhibrx Biosciences IncINBX | COM | 45720N103 | 24.3 | 2.5% | 256,950 | New+256,950 | |
| Xenon Pharmaceuticals IncXENE | COM | 98420N105 | 24.0 | 2.5% | 397,379 | Reduced−99,656 | |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 23.4 | 2.4% | 577,036 | Added+254,208 | |
| Unitedhealth Group IncUNH | COM | 91324P102 | 23.2 | 2.4% | 55,921 | New+55,921 | |
| Stryker CorporationSYK | COM | 863667101 | 21.4 | 2.2% | 67,973 | Reduced−86,798 | |
| Iqvia Holdings IncIQV | COM | 46266C105 | 20.4 | 2.1% | 105,811 | Added+19,109 | |
| Zimmer Biomet Holdings IncZBH | COM | 98956P102 | 20.0 | 2.0% | 232,557 | Reduced−37,000 | |
| Insulet CorpPODD | COM | 45784P101 | 20.0 | 2.0% | 131,378 | Reduced−25,183 | |
| Assembly Biosciences IncASMB | COM NEW | 045396207 | 19.8 | 2.0% | 721,181 | Added+309,954 | |
| Syndax Pharmaceuticals IncSNDX | COM | 87164F105 | 19.2 | 2.0% | 877,256 | Reduced−24,255 | |
| Eyepoint IncEYPT | COM NEW | 30233G209 | 18.4 | 1.9% | 1,288,163 | Reduced−66,637 | |
| Tenet Healthcare CorpTHC | COM NEW | 88033G407 | 18.2 | 1.9% | 97,280 | Added+47,157 | |
| Livanova plc | SHS | G5509L101 | 17.3 | 1.8% | 210,529 | Reduced−193,436 | |
| ANI Pharmaceuticals IncANIP | COM | 00182C103 | 16.8 | 1.7% | 202,907 | Reduced−77,668 | |
| Biocryst Pharmaceuticals IncBCRX | COM | 09058V103 | 16.2 | 1.7% | 1,624,279 | Reduced−83,820 | |
| Alnylam Pharmaceuticals IncALNY | COM | 02043Q107 | 15.3 | 1.6% | 50,672 | Added+23,756 | |
| Indivior Pharmaceuticals IncINDV | COM | 45579U109 | 14.9 | 1.5% | 364,269 | New+364,269 | |
| Envista Holdings CorporationNVST | COM | 29415F104 | 14.6 | 1.5% | 553,916 | Reduced−157,777 | |
| Bright Minds Biosciences IncDRUG | COM NEW | 10919W405 | 14.4 | 1.5% | 205,053 | Added+164,955 | |
| Xeris Biopharma Holdings IncXERS | COM | 98422E103 | 14.3 | 1.5% | 1,807,621 | Added+86,357 | |
| Avalo Therapeutics IncAVTX | COM NEW | 05338F306 | 14.2 | 1.4% | 766,290 | New+766,290 | |
| 4D Molecular Therapeutics inFDMT | COM | 35104E100 | 12.6 | 1.3% | 948,184 | Added+425,607 | |
| Immunome IncIMNM | COM | 45257U108 | 12.6 | 1.3% | 594,202 | Added+190,715 | |
| Stoke Therapeutics IncSTOK | COM | 86150R107 | 11.6 | 1.2% | 355,443 | Added+18,924 | |
| Waters CorpWAT | COM | 941848103 | 11.3 | 1.2% | 30,206 | Added+3,759 | |
| Alto Neuroscience IncANRO | COM SHS | 02157Q109 | 11.3 | 1.2% | 429,035 | New+429,035 | |
| Oruka Therapeutics IncORKA | COM | 687604108 | 10.8 | 1.1% | 113,188 | New+113,188 | |
| Adaptive Biotechnologies CorADPT | COM | 00650F109 | 10.4 | 1.1% | 486,984 | Reduced−64,831 | |
| Absci CorporationABSI | COM | 00091E109 | 10.4 | 1.1% | 894,374 | Reduced−970,432 | |
| Mineralys Therapeutics IncMLYS | COM | 603170101 | 10.3 | 1.1% | 380,354 | Added+217 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 9.8 | 1.0% | 253,365 | Added+153,239 | |
| Uniqure NV | SHS | N90064101 | 9.6 | 1.0% | 208,170 | Added+1,328 | |
| Tarsus Pharmaceuticals IncTARS | COM | 87650L103 | 9.4 | 1.0% | 150,000 | New+150,000 | |
| Amneal Pharmaceuticals IncAMRX | COM STK CL A | 03168L105 | 9.4 | 1.0% | 541,190 | Added+240,438 | |
| Irhythm Holdings IncIRTC | COM | 450056106 | 8.0 | 0.8% | 67,267 | Added+27,142 | |
| Cryoport IncCYRX | COM PAR $0.001 | 229050307 | 8.0 | 0.8% | 508,324 | New+508,324 | |
| Boston Scientific CorpBSX | COM | 101137107 | 7.7 | 0.8% | 180,481 | Reduced−268,287 | |
| Climb Bio IncCLYM | COM | 28658R106 | 7.3 | 0.8% | 563,484 | New+563,484 | |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 7.2 | 0.7% | 398,782 | Reduced−222,676 | |
| Upstream Bio IncUPB | COM | 91678A107 | 6.5 | 0.7% | 935,247 | Added+148,464 | |
| Resmed IncRMD | COM | 761152107 | 6.4 | 0.7% | 32,983 | New+32,983 | |
| Urogen Pharma Ltd | COM | M96088105 | 6.4 | 0.7% | 174,064 | Reduced−100,936 | |
| Align Technology IncALGN | COM | 016255101 | 6.2 | 0.6% | 36,963 | Added+15,730 | |
| Carlsmed IncCARL | COM | 14280C105 | 6.2 | 0.6% | 597,318 | Added+76,195 | |
| Aveanna Healthcare Holdings IncAVAH | COM | 05356F105 | 6.1 | 0.6% | 714,451 | New+714,451 | |
| Caredx IncCDNA | COM | 14167L103 | 5.8 | 0.6% | 202,417 | Reduced−88,961 | |
| SI Bone IncSIBN | COM | 825704109 | 5.4 | 0.5% | 328,686 | Reduced−44,867 | |
| VIR Biotechnology IncVIR | COM | 92764N102 | 4.8 | 0.5% | 475,279 | Reduced−24,721 | |
| Erasca IncERAS | COM | 29479A108 | 4.7 | 0.5% | 258,684 | Reduced−148,018 | |
| Shoulder Innovations IncSI | COMMON STOCK | 82537J108 | 4.6 | 0.5% | 226,212 | New+226,212 | |
| Waystar HLDG CorpWAY | COM | 946784105 | 4.2 | 0.4% | 203,986 | Reduced−239,072 | |
| Alphatec Holdings IncATEC | COM NEW | 02081G201 | 3.9 | 0.4% | 449,943 | Reduced−373,820 | |
| Annexon IncANNX | COM | 03589W102 | 3.7 | 0.4% | 641,029 | Reduced−32,984 | |
| Castle Biosciences IncCSTL | COM | 14843C105 | 3.5 | 0.4% | 144,791 | Added+18,641 | |
| Minimed Group IncMMED | COM | 60365F109 | 3.4 | 0.3% | 226,446 | Reduced−90,878 | |
| Eikon Therapeutics IncEIKN | COM | 282564103 | 3.3 | 0.3% | 256,053 | New+256,053 | |
| Viatris IncVTRS | COM | 92556V106 | 3.2 | 0.3% | 200,000 | New+200,000 | |
| Grail Inc | PUT | 384747951 | 3.1 | 0.3% | 46,000 | Put | New+46,000 |
| Artivion IncAORT | COM | 228903100 | 3.1 | 0.3% | 138,940 | Reduced−113,074 | |
| Axsome Therapeutics Inc.AXSM | COM | 05464T104 | 2.4 | 0.3% | 10,000 | New+10,000 | |
| Optimizerx CorpOPRX | COM NEW | 68401U204 | 2.0 | 0.2% | 350,347 | Reduced−379,022 | |
| Inspiremd IncNSPR | COM | 45779A846 | 1.7 | 0.2% | 2,416,518 | Unchanged | |
| Hemab Therapeutics Holdings IncCOAG | COM SHS | 423494103 | 1.7 | 0.2% | 45,000 | New+45,000 | |
| Pulmonx CorpLUNG | COM | 745848101 | 0.8 | <0.1% | 646,564 | Reduced−109,072 | |
| ARS Pharmaceuticals IncSPRY | COM | 82835W108 | 0.8 | <0.1% | 102,700 | New+102,700 | |
| Edap TMS S aFOCL | SPONSORED ADR | 268311107 | 0.8 | <0.1% | 154,832 | Unchanged | |
| Ovid Therapeutics IncOVID | COM | 690469101 | 0.5 | <0.1% | 197,947 | Reduced−10,258 | |
| Entera Bio Ltd | SHS | M40527109 | 0.5 | <0.1% | 274,497 | Reduced−14,173 |
Sold out: 31 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Abbvie IncABBV | COM | 00287Y109 | 0.0 | 0.0% | 0 | Sold out−75,000 | |
| Accuray Inc DelARAY | COM | 004397105 | 0.0 | 0.0% | 0 | Sold out−884,578 | |
| Adma Biologics IncADMA | COM | 000899104 | 0.0 | 0.0% | 0 | Sold out−82,443 | |
| Apogee Therapeutics Inc | COM | 03770N101 | 0.0 | 0.0% | 0 | Sold out−77,686 | |
| Axogen IncAXGN | COM | 05463X106 | 0.0 | 0.0% | 0 | Sold out−268,160 | |
| Butterfly Network IncBFLY | COM CL A | 124155102 | 0.0 | 0.0% | 0 | Sold out−544,477 | |
| Caris Life Sciences IncCAI | COM | 142152107 | 0.0 | 0.0% | 0 | Sold out−229,912 | |
| Compass Pathways plcCMPS | SPONSORED ADS | 20451W101 | 0.0 | 0.0% | 0 | Sold out−554,411 | |
| Cooper Cos IncCOO | COM | 216648501 | 0.0 | 0.0% | 0 | Sold out−89,883 | |
| CVRX IncCVRX | COM | 126638105 | 0.0 | 0.0% | 0 | Sold out−429,507 | |
| Edwards Lifesciences CorpEW | COM | 28176E108 | 0.0 | 0.0% | 0 | Sold out−167,155 | |
| Genedx Holdings CorpWGS | COM CL A | 81663L200 | 0.0 | 0.0% | 0 | Sold out−50,778 | |
| Idexx Labs IncIDXX | COM | 45168D104 | 0.0 | 0.0% | 0 | Sold out−15,000 | |
| Illumina IncILMN | COM | 452327109 | 0.0 | 0.0% | 0 | Sold out−110,370 | |
| Kalvista Pharmaceuticals Inc | COM | 483497103 | 0.0 | 0.0% | 0 | Sold out−1,835,506 | |
| Kiniksa Pharmaceuticals International | ORD SHS CL A | G52694109 | 0.0 | 0.0% | 0 | Sold out−259,184 | |
| Maze Therapeutics IncMAZE | COM | 578784100 | 0.0 | 0.0% | 0 | Sold out−31,844 | |
| McKesson CorpMCK | COM | 58155Q103 | 0.0 | 0.0% | 0 | Sold out−12,676 | |
| Moderna Inc | PUT | 60770K957 | 0.0 | 0.0% | 0 | Put | Sold out−100,000 |
| Neurocrine Biosciences IncNBIX | COM | 64125C109 | 0.0 | 0.0% | 0 | Sold out−99,069 | |
| Nuvalent Inc | COM | 670703107 | 0.0 | 0.0% | 0 | Sold out−88,078 | |
| Pulse Biosciences IncPLSE | COM | 74587B101 | 0.0 | 0.0% | 0 | Sold out−50,125 | |
| Qiagen NV | ORD SHARES | N72482156 | 0.0 | 0.0% | 0 | Sold out−500,000 | |
| Quanterix CorpQTRX | COM | 74766Q101 | 0.0 | 0.0% | 0 | Sold out−341,453 | |
| Quidelortho CorpQDEL | COM | 219798105 | 0.0 | 0.0% | 0 | Sold out−101,764 | |
| Rxsight IncRXST | COM | 78349D107 | 0.0 | 0.0% | 0 | Sold out−249,989 | |
| Solid Biosciences IncSLDB | COM NEW | 83422E204 | 0.0 | 0.0% | 0 | Sold out−308,844 | |
| Supernus PharmaceuticalsSUPN | COM | 868459108 | 0.0 | 0.0% | 0 | Sold out−85,062 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 0.0 | 0.0% | 0 | Sold out−266,127 | |
| Ultragenyx Pharmaceutical inRARE | COM | 90400D108 | 0.0 | 0.0% | 0 | Sold out−235,000 | |
| Veracyte IncVCYT | COM | 92337F107 | 0.0 | 0.0% | 0 | Sold out−101,237 |
Source: SEC EDGAR, Form 13F-HR, accession 0001420506-26-001734 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.